TrialAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

PRDM1+ Malignant Cells Mediate an Immunosuppressive Landscape and Resistance to Neoadjuvant Chemoradiotherapy and Immunotherapy in Esophageal Squamous Cell Carcinoma.

Dijian Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.